早期类风湿性关节炎初始治疗的全球模式和预测因素:来自跨国机器学习研究的见解
David Vega-Morales1, Pedro Machado2, Sytske Anne Bergstra3
1Instituto Mexicano del Seguro Social, Rheumatology and Infusion Center, Hospital General de Zona 17, Monterrey, Mexico. drdavidvega@yahoo.com.mx.
Clinical rheumatology
|March 9, 2026
概括
机器学习将年龄和临床疾病活动确定为类风湿性关节炎治疗决策的关键因素,往往会掩盖实验室结果. 这些发现支持早期类风湿性关节炎 (RA) 的个性化,数据驱动的护理.
科学领域:
- 类风湿病学 类风湿病学
- 医疗信息学 医疗信息学
- 人工智能在医学中的应用
背景情况:
- 风湿性关节炎 (RA) 治疗指南强调早期启动疾病修饰性抗风湿药物 (DMARD).
- 临床实践涉及到影响RA治疗选择的复杂因素,超出了指导方针.
- 机器学习 (ML) 提供了分析治疗模式和个性化护理的潜力.
研究的目的:
- 使用ML算法识别最初RA治疗的关键预测因素.
- 分析一大批国际新诊断的RA患者的治疗决策.
主要方法:
- 来自METEOR注册表的16684名患者的二次分析.
- 随机森林模型使用人口统计,临床指标,血清学标记和原产国.
- 模型性能通过准确性,精度,回忆和通用性进行评估;通过吉尼系数评估变量重要性.
主要成果:
- 甲二甲酸加上葡萄糖皮质类药物是最常见的初始治疗方案 (26.1%).
- 年龄成为最强的预测因素,其次是炎症负担 (ESR,关节计数,HAQ-DI).
- 血清标记 (RF,ACPA) 和成像 (侵蚀) 的预测能力较低. 最顶级的模型实现了0.97准确度.
结论:
- 在现实世界中,RA的初始治疗主要取决于患者的年龄和临床疾病活性.
- 机器学习模型可以阐明复杂的处方模式,并为质量改进计划提供信息.
- 在早期的RA治疗中,临床决策支持的整合需要进一步验证.
相关概念视频
01:11Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
01:21Rheumatic Heart Disease III: Medical Management
445
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
870
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
870
01:23Rheumatic Heart Disease I: Introduction
711
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
711
01:20The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K